Innoviva
INVA
#5200
Rank
NZ$2.61 B
Marketcap
NZ$34.99
Share price
4.90%
Change (1 day)
5.86%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2025 (TTM): NZ$0.26 Billion

According to Innoviva's latest financial reports the company's current earnings are NZ$0.38 Billion. In 2024 the company made an earning of NZ$62.35 Million a decrease over its 2023 earnings that were of NZ$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.26 B322.84%
2024 NZ$62.35 M-80.74%
2023 NZ$0.32 B-32.36%
2022 NZ$0.47 B-35.56%
2021 NZ$0.74 B25.7%
2020 NZ$0.59 B52.11%
2019 NZ$0.38 B10.77%
2018 NZ$0.35 B56.59%
2017 NZ$0.22 B125.53%
2016 NZ$99.29 M-417.36%
2015 -NZ$31.29 Million-74.49%
2014 -NZ$0.13 Billion-25.19%
2013 -NZ$0.17 Billion430.06%
2012 -NZ$30.93 Million-83.92%
2011 -NZ$0.2 Billion39.82%
2010 -NZ$0.14 Billion2.84%
2009 -NZ$0.14 Billion-8.62%
2008 -NZ$0.15 Billion-47.92%
2007 -NZ$0.29 Billion-5.92%
2006 -NZ$0.3 Billion19.8%
2005 -NZ$0.25 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.27 Billion-201.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.29 Million-111.60%๐Ÿ‡บ๐Ÿ‡ธ USA